Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment

IF 1.7 Q4 INFECTIOUS DISEASES IJID regions Pub Date : 2024-12-21 DOI:10.1016/j.ijregi.2024.100556
Harsh Shah, Jay Patel, Sandeep Rai, Abhishek Sen
{"title":"Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment","authors":"Harsh Shah,&nbsp;Jay Patel,&nbsp;Sandeep Rai,&nbsp;Abhishek Sen","doi":"10.1016/j.ijregi.2024.100556","DOIUrl":null,"url":null,"abstract":"<div><div>Tuberculosis (TB), caused by <em>Mycobacterium tuberculosis</em>, remains a global health challenge, despite being preventable and curable. The global goal to end TB by 2030, with India targeting a 90% reduction in TB incidence by 2025, demands comprehensive interventions in prevention, early detection, treatment, and capacity building. This study analyzes the 2023 Global TB Reports, published articles, guidelines, and data to explore India's current TB landscape. Despite progress in diagnostics and TB preventive treatment, significant challenges persist in accessibility, adherence, and treatment completion. Although advancements in household contact screening and TB preventive treatment initiation are notable, gaps in reporting, diagnostic algorithms, and adherence remain. Innovative diagnostic tools and shorter treatment regimens show promise but require more comprehensive implementation. India's strategy for TB elimination focuses on policy expansion, community engagement, and system enhancements. Continuous innovation, rigorous evaluation, and collaborative efforts are crucial to overcoming challenges and meeting TB elimination targets.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"14 ","pages":"Article 100556"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761892/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJID regions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277270762400225X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a global health challenge, despite being preventable and curable. The global goal to end TB by 2030, with India targeting a 90% reduction in TB incidence by 2025, demands comprehensive interventions in prevention, early detection, treatment, and capacity building. This study analyzes the 2023 Global TB Reports, published articles, guidelines, and data to explore India's current TB landscape. Despite progress in diagnostics and TB preventive treatment, significant challenges persist in accessibility, adherence, and treatment completion. Although advancements in household contact screening and TB preventive treatment initiation are notable, gaps in reporting, diagnostic algorithms, and adherence remain. Innovative diagnostic tools and shorter treatment regimens show promise but require more comprehensive implementation. India's strategy for TB elimination focuses on policy expansion, community engagement, and system enhancements. Continuous innovation, rigorous evaluation, and collaborative efforts are crucial to overcoming challenges and meeting TB elimination targets.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
推动在印度消除结核病:对结核病预防治疗的现行战略和有待改进的领域进行定性审查。
由结核分枝杆菌引起的结核病尽管可以预防和治愈,但仍然是一项全球卫生挑战。到2030年终结结核病的全球目标(印度的目标是到2025年将结核病发病率降低90%)要求在预防、早期发现、治疗和能力建设方面采取综合干预措施。本研究分析了《2023年全球结核病报告》、已发表的文章、指南和数据,以探讨印度目前的结核病形势。尽管在诊断和结核病预防治疗方面取得了进展,但在可及性、坚持治疗和完成治疗方面仍然存在重大挑战。尽管在家庭接触者筛查和开始结核病预防性治疗方面取得了显著进展,但在报告、诊断算法和坚持治疗方面仍然存在差距。创新的诊断工具和较短的治疗方案显示出希望,但需要更全面的实施。印度的消除结核病战略侧重于扩大政策、社区参与和加强系统。持续创新、严格评估和合作努力对于克服挑战和实现消除结核病目标至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
IJID regions
IJID regions Infectious Diseases
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
64 days
期刊最新文献
Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study’ [IJID Regions, volume 17 (2025) 100786] Survival after cardiopulmonary arrest due to Capnocytophaga canimorsus sepsis: A case successfully managed using plasma exchange Persistent nasal colonization of rare community-acquired methicillin-resistant Staphylococcus aureus clones ST8-IVl (CA-MRSA/J) and ST1930-IVa in healthy adults Pre-exposure prophylaxis in Guyana: linking key populations and other vulnerable groups Agreement and systematic bias between QuantiFERON chemiluminescent immunoassay and QuantiFERON enzyme-linked immunosorbent assay in the detection of latent tuberculosis infection: A systematic review and meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1